Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Emerg Med J ; 21(5): 533-6, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15333522

ABSTRACT

OBJECTIVES: To describe the development of emergency medicine (EM) in Israel and review the specific problems faced by the discipline and describe the solutions that were found. METHODS: A comprehensive literature search was conducted for data on development of EM in the UK and in North America, and the personal knowledge of two of the authors (PH and YW) was used in preparing the article. RESULTS: There are differences in development of EM between Israel and the UK/US models. In Israel the specialty developed within the context of established high quality clinical practice and consequently it met resistance from the system, which did not wish to invest in what it felt might be marginal improvements in patient care. The economics of Israeli medicine also dictated that EM be made into a super-specialty rather than a primary specialty. Certified specialists from family medicine, paediatrics, internal medicine, general surgery, anaesthesia, and orthopaedic surgery can access training positions in EM. Currently there are seven active EM programmes of 2.5 years duration and 16 residents. The curriculum is flexible and a national certification examination is being developed. CONCLUSIONS: Development of EM can and should take different paths according to the specific local needs and realities. There is no single ideal model suitable for all circumstances. The practice of clinical EM in Israel is comparable with that of any developed country and daily progress is being made in the academic areas of teaching and research. There are worldwide similarities in the process of developing EM as a distinct discipline.


Subject(s)
Education, Medical, Graduate/trends , Emergency Medicine/education , Models, Educational , Cross-Cultural Comparison , Curriculum , Education, Medical, Graduate/organization & administration , Education, Medical, Graduate/standards , Humans , Israel , Specialization/economics , Specialization/standards , United Kingdom , United States
3.
Isr Med Assoc J ; 2(2): 142-4, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10804939

ABSTRACT

BACKGROUND: Extensive cleaning of homes in Israel before Passover may result in increased exposure of children to cleaning substances. OBJECTIVES: To evaluate the potential danger of Passover cleaning to children, and to study the risk factors in order to identify areas for prevention. METHODS: All cases of poison exposure in Jewish and Arab children under the age of 15 years reported to the Israel Poison Information Center during 1990-95 (n = 5,583) were analyzed for the 6 weeks before and 6 weeks after Passover. Poison exposures in Jewish children < 15 years old were studied in seven pediatric emergency rooms for the 2 weeks before and 6 weeks after Passover (n = 123). RESULTS: The IPIC data showed a highly significant 38% increase in the average weekly poison exposure rate for the 2 weeks before Passover compared with the remaining 10 weeks. Data recorded by the pediatric emergency rooms showed a twofold increase in cleaning substance poisoning during the 2 weeks before Passover compared with the following 6 weeks. The rise in exposures to cleaning substances was observed among children from secular, religious and ultra-orthodox families. In these exposures, the substance was found in open containers in 70% of cases. CONCLUSIONS: The extensive cleaning of homes among Jewish families in preparation for Passover poses the danger to young children of cleaning substance poisoning. Increasing public awareness, closer observation of children, and keeping these substances in closed containers should increase children's safety during this annual cleaning.


Subject(s)
Holidays , Household Products/adverse effects , Household Work , Jews/statistics & numerical data , Poisoning/epidemiology , Adolescent , Analysis of Variance , Child , Child, Preschool , Humans , Infant , Israel/epidemiology , Judaism , Poisoning/prevention & control , Prospective Studies
5.
Pediatrics ; 104(4): e41, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10506266

ABSTRACT

OBJECTIVE: To determine the validity of the Uriscreen, a rapid diagnostic test based on the detection of urine catalase for the early detection of urinary tract infection (UTI) in children, compared with standard urinalysis and dipstick tests. STUDY DESIGN. Cross-sectional study. STUDY POPULATION: Children 1 month to 17 years of age who presented to the emergency department of a pediatric tertiary care center between March and November of 1996 with symptoms suggestive of UTI. METHODS: Urine specimens obtained from a random sample of 121 patients were evaluated simultaneously for possible UTI by Uriscreen (catalase test), urinalysis (microscopic pyuria), dipstick (leukocyte esterase and nitrite), and quantitative urine culture. All specimens were collected by one of three sterile techniques (midstream void technique, bladder catheterization, or suprapubic aspiration), as appropriate for age, and tested immediately. Using the quantitative urine culture as the gold standard (reference test), the sensitivity, specificity, and positive and negative predictive values of all the screening tests were determined and compared. Age, sex, temperature, presenting symptoms, and method of urine collection were recorded for each participant. RESULTS: Of the 121 patients, 35 (28.9%) had positive culture results: 30 girls (85.7%) and 5 boys (14.3%). Compared with urinalysis and dipstick tests, Uriscreen had the highest sensitivity (100% vs 88.6% and 97.1%, respectively) and the highest negative predictive value (100% vs 95% and 98.6%, respectively), but the poorest specificity (68.6% vs 88.4% and 82.5%, respectively) and positive predictive value (56.4% vs 75.6% and 69.4%, respectively). CONCLUSIONS: The clinical use of Uriscreen for the presumptive diagnosis of UTI in children is limited and not significantly superior to urinalysis or the dipstick test. However, because of its 100% sensitivity and negative predictive value and its ease of use, rapidity, and low cost, it is recommended highly for ruling out the diagnosis of UTI. In laboratories, a negative Uriscreen result may prevent the need for performing expensive urine cultures.


Subject(s)
Catalase/analysis , Urinary Tract Infections/diagnosis , Bacteriuria/diagnosis , Colony Count, Microbial , Cross-Sectional Studies , Female , Humans , Infant , Male , Predictive Value of Tests , Pyuria/diagnosis , Random Allocation , Reagent Strips , Sensitivity and Specificity , Urinalysis , Urine/chemistry , Urine/microbiology
6.
Pediatr Emerg Care ; 15(5): 314-7, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10532657

ABSTRACT

OBJECTIVE: To review the emergency department management of children with aseptic meningitis and compare the clinical features, laboratory findings, and short-term follow-up of those who were hospitalized or discharged to determine guidelines for discharge. DESIGN: Retrospective chart review study. SETTING: Emergency department of an inner-city teaching, level III, children's hospital during an outbreak of aseptic meningitis from, March through December 1993. METHODS: The medical records of children < or = 18 years of age diagnosed in the emergency department with aseptic meningitis after lumbar puncture were retrospectively reviewed and analyzed. Thirty-four parameters were recorded for each child including demographic (2), epidemiologic (5), clinical (2), laboratory (10), and short-term follow-up data (5). RESULTS: Of the 158 eligible patients, 99 (62.7%) were hospitalized, and 59 (37.3%) were discharged. Compared to the hospitalized group, children who were discharged were significantly older (5.7 years vs. 4.7 years, P < 0.05) and experienced a more benign course, with lower rates of headache (54.7 vs. 85.7%, P < 0.05), vomiting (38.2 vs. 69.7%, P < 0.05), and irritability (1.8 vs. 8.1%, P < 0.05). They also had significantly (P < 0.05) lower mean peripheral and cerebrospinal fluid leukocyte counts (13,233 vs. 11,498/mm3 and 293.91 vs. 105.29/mm3, respectively). Interestingly, 30 (50.8%) of children in the discharged group had over 50% polymorphonuclears in their cerebrospinal fluid (CSF) cell count. The hospitalization rate during the day was significantly (P < 0.05) lower than that for the evening and night shifts (51.5 vs. 66.7%, respectively). In the discharged group, symptoms of headache, fever, and vomiting resolved after an average of 3.05 days, 2.25 days, and 1.3 days, respectively. The average hospitalization time was 3.5 days. There were no significant complications in either group. More important, in neither group were there any misdiagnoses of bacterial meningitis as aseptic meningitis. During the study period, the ambulatory management of the 59 patients cost $51,625 less than the hospitalization of an equal number of children. CONCLUSION: It is feasible, clinically safe and less costly to treat a subgroup of children with aseptic meningitis in an ambulatory setting. Although absolute criteria for ambulatory follow-up could not be defined, age >1 year, a nontoxic clinical appearance, normal white blood cell count, mild cerebrospinal fluid pleocytosis (even with a high percentage of polymorphonuclear cells), negative CSF Gram stain, and a reliable family setting could serve as guidelines for decision-making regarding emergency department discharge. Further prospective research is needed to better specify these criteria.


Subject(s)
Emergency Service, Hospital , Meningitis, Aseptic/therapy , Acute Disease , Adolescent , Child , Child, Preschool , Disease Outbreaks , Female , Hospitalization/statistics & numerical data , Humans , Infant , Infant, Newborn , Israel/epidemiology , Male , Meningitis, Aseptic/blood , Meningitis, Aseptic/cerebrospinal fluid , Meningitis, Aseptic/epidemiology
7.
Ann Allergy Asthma Immunol ; 81(6): 563-70, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9892028

ABSTRACT

BACKGROUND: The worldwide increase in the incidence, prevalence, and severity of asthma may suggest that environmental factors play a role in these epidemiologic changes. OBJECTIVE: To examine the correlations between air pollutants, weather conditions, airborne allergens, and the incidence of emergency room (ER) visits of children with acute asthma attacks. DESIGN: One-year prospective study. Data of daily concentration of air pollutants, weather conditions, and selective airborne allergens were collected and compared with the number of ER visits of asthmatic children. SUBJECTS: 1076 asthmatic children (aged 1 to 18 years) who presented at the Pediatric ER between January 1 and December 31, 1993. RESULTS: Correlations between fluctuations in ER visits of asthmatic children and various environmental parameters were more relevant for weekly than for daily values. Emergency room visits correlated positively with concentrations of NOx, SO2 and with high barometric pressure; and negatively with O3 concentration and minimal and maximal temperature. There were no significant correlations with concentrations of particulates, humidity, or airborne pollen and spores. An exceptionally high incidence of ER visits of asthmatic children was observed during September. This peak coincided with the beginning of the school year and the Jewish holidays. The correlations between ER visits and the environmental factors increased significantly when the September peak was excluded, revealing that 61% of the variance in ER visits was explained by NOx, SO2, and 03 concentrations, 46% by weather parameters, 66% by NOx, SO2 and barometric pressure, and 69% by the combination of air pollutants and weather parameters. CONCLUSION: The major factors found to be associated with ER visits of asthmatic children were high NOx, high SO2, and high barometric pressure. Negative correlation was found between ER visits of asthmatic children and ozone concentrations. The particularly high number of ER visits at the beginning of the school year and the Jewish holidays was probably associated with an increase in the number of viral infections and/or emotional stress.


Subject(s)
Air Pollution , Asthma/epidemiology , Emergency Service, Hospital/statistics & numerical data , Adolescent , Air Pollutants/chemistry , Air Pollution/analysis , Air Pollution/statistics & numerical data , Air Pressure , Allergens/analysis , Child , Child, Preschool , Female , Humans , Incidence , Infant , Israel/epidemiology , Male , Morbidity , Nitrogen Oxides/analysis , Ozone/analysis , Pollen , Prospective Studies , Regression Analysis , Seasons , Sulfur Dioxide/analysis , Temperature , Time Factors , Weather
8.
Pediatr Emerg Care ; 13(2): 92-4, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9127414

ABSTRACT

OBJECTIVE: To compare treatment of ongoing seizures using intramuscular (IM) midazolam versus intravenous (IV) diazepam. DESIGN: Controlled clinical trial. PATIENTS: Children with motor seizures of at least 10 minutes' duration. MAIN OUTCOME MEASURES: Time to cessation of seizures. RESULTS: Twenty-four patients were enrolled (13 midazolam, 11 diazepam). Initial treatment with either midazolam or diazepam was successful in 22 of the 24 patients. One patient in each group failed therapy and eventually required endotracheal intubation and general anesthesia for convulsive status epilepticus lasting more than one hour. Patients in the midazolam group received medication sooner (3.3 +/- 2.0 vs 7.8 +/- 3.2 minutes, P = 0.001) and had more rapid cessation of their seizures (7.8 +/- 4.1 vs 11.2 +/- 3.6, P = 0.047) than patients randomized to receive diazepam. CONCLUSIONS: IM midazolam is an effective anticonvulsant for children with motor seizures. Compared to IV diazepam, IM midazolam results in more rapid cessation of seizures because of more rapid administration. The IM route of administration may be particularly useful in physicians' offices, in the prehospital setting, and for children with difficult IV access.


Subject(s)
Anti-Anxiety Agents/administration & dosage , Anticonvulsants/administration & dosage , Diazepam/administration & dosage , Midazolam/administration & dosage , Seizures/drug therapy , Child , Child, Preschool , Female , Humans , Infant , Infusions, Intravenous , Injections, Intramuscular , Male , Prospective Studies , Recurrence , Time Factors
10.
Ann Emerg Med ; 26(5): 640-2, 1995 Nov.
Article in English | MEDLINE | ID: mdl-7486375

ABSTRACT

Emergency medicine is in its infancy in Israel but is developing rapidly. Medical and government authorities such as the Israeli Medical Association and the Israeli Ministry of Health have already recognized the need for this field in Israel, although it remains for emergency medicine to be recognized as an independent medical specialty. Those involved in the intense process of obtaining formal recognition believe this will occur in the next year.


Subject(s)
Emergency Medicine/organization & administration , Specialization , Emergency Medicine/education , Health Services Needs and Demand , Humans , Israel , Public Health , Research , Societies, Medical
11.
J Appl Physiol (1985) ; 77(5): 2366-73, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7532649

ABSTRACT

We investigated the effects of recombinant granulocyte colony-stimulating factor (G-CSF) in a canine model of septic shock. Awake 2-yr-old beagles were studied before and after intraperitoneal placement of an Escherichia coli-infected clot. Nine days before and until 3 days after clot placement, animals received daily high-dose (G-CSF (5 microgram/kg body wt; n = 17), low-dose G-CSF (0.1 microgram/kg body wt; n = 17), or a control protein (5 micrograms/kg body wt; n = 20). Survival rate was greater (P < 0.04, Wilcoxon test) in the high-dose G-CSF group (14/17) than in the low-dose G-CSF (10/17) and control (12/20) groups. High-dose G-CSF improved cardiovascular function, as evidenced by increased left ventricular ejection fraction (day 1 after clot; P < 0.001) and mean arterial pressure (day 2; P < 0.02) compared with low-dose G-CSF and control groups. High-dose G-CSF increased (P < 0.001) mean peripheral neutrophils before (-3 days) and after (2 h to 4 days) clot and produced a more rapid (P < 0.001) rise (day 2) and fall (day 4) in mean alveolar neutrophil numbers compared with the low-dose G-CSF and control groups. High-dose G-CSF decreased mean serum endotoxin (2-8 h; P < 0.002) and tumor necrosis factor (2 h; P < 0.02) levels and lowered blood bacteria counts (2-6 h; P < 0.04) compared with the low-dose G-CSF and control groups. Thus, in this canine model, G-CSF sufficient to increase peripheral neutrophils before and during peritonitis and septic shock enhances host defense, reduces cytokine (tumor necrosis factor) levels, and improves cardiovascular function and survival.


Subject(s)
Bronchoalveolar Lavage Fluid/immunology , Granulocyte Colony-Stimulating Factor/pharmacology , Hemodynamics , Neutrophils/immunology , Shock, Septic/physiopathology , Animals , Blood Gas Analysis , Colony Count, Microbial , Dogs , Endotoxins/blood , Escherichia coli/isolation & purification , Escherichia coli Infections/immunology , Escherichia coli Infections/microbiology , Escherichia coli Infections/physiopathology , Granulocyte Colony-Stimulating Factor/administration & dosage , Leukocyte Count , Recombinant Proteins/pharmacology , Shock, Septic/immunology , Shock, Septic/microbiology , Stroke Volume , Tumor Necrosis Factor-alpha/metabolism
12.
Clin Pediatr (Phila) ; 33(11): 642-6, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7859421

ABSTRACT

We conducted a controlled clinical trial to determine the efficacy of single-dose intramuscular ceftriaxone for the treatment of acute otitis media. Fifty-four children aged 18 months to 6 years with clinical and tympanometric evidence of otitis media were randomized to receive either 50 mg/kg ceftriaxone or 10 days of oral cefaclor 40 mg/kg/day. Resolution of symptoms and clinical and tympanometric appearance of the tympanic membrane at follow-up visits were used to determine outcome. Thirty-one children received ceftriaxone and 23 received oral cefaclor. There were no treatment failures. There were no significant differences between groups in persistence of effusion or recurrence of acute otitis media. We conclude that a single intramuscular dose of ceftriaxone compares favorably with 10 days of oral cefaclor for the treatment of acute otitis media.


Subject(s)
Cefaclor/administration & dosage , Ceftriaxone/administration & dosage , Otitis Media/drug therapy , Acute Disease , Administration, Oral , Child , Child, Preschool , Female , Humans , Infant , Injections, Intramuscular , Male , Treatment Outcome
13.
Isr J Med Sci ; 30(8): 651-6, 1994 Aug.
Article in English | MEDLINE | ID: mdl-8045752

ABSTRACT

Although controversy still exists about dispensing medical advice over the telephone, such services are widely offered by pediatricians in the USA. In Israel, however, such services have not yet been developed. In a joint project of the Moked Keshev (a private medical help line) at Magen David Adom (national ambulance service) and the Children's Medical Center of Israel, the first pediatric telephone advice service in Israel was established. In this study we analyzed 512 consecutive incoming calls received during the first 11 months of service operation. Of these, 42% of calls concerned children in the 1 month to 1 year age group. Unexpectedly, calls were almost evenly distributed throughout the week with a slight decrease on Fridays and Saturdays (sabbath), and 45.7% of the calls were received during the morning shift. The three most common reasons for contact were: of a general nature such as fever (23%), gastrointestinal problems (19%), and medical questions (18%). In only 20.7% of the cases were the patients advised to go to the nearest hospital emergency department, emphasizing the non-emergent nature of the calls. At the time of follow-up (within 24 h), patient status was assessed as: improved (73.7%), same (22.6%), and worse (3.8%). Of those who became worse, none required an emergency department evaluation. The present study demonstrates that a Pediatric Telephone Advice Service in Israel is technically functional, medically safe, and contributes to the health management of children.


Subject(s)
Hospitals, Pediatric/organization & administration , Hotlines , Pediatrics/organization & administration , Telephone/statistics & numerical data , Adolescent , Algorithms , Child , Child, Preschool , Hospitals, Pediatric/statistics & numerical data , Humans , Infant , Israel
14.
J Pediatr ; 123(5): 817-21, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8229498

ABSTRACT

We compared the clinical and bacteriologic response of 5-day treatment with cefixime, 8 mg/kg per day, with the response to trimethoprim-sulfamethoxazole (TMP-SMX), 10-50 mg/kg per day, the currently recommended therapy. Of the assessable children with acute, culture-proven shigellosis, 38 received cefixime and 39 received TMP-SMX. Pretreatment data on the two study groups were similar. In the first group, all isolates were susceptible to cefixime; in the TMP-SMX group, 32 isolates were resistant and 7 were susceptible to TMP-SMX. Clinical response (day 5) showed cure, improvement, and failure in 89%, 8%, and 3%, respectively, of the cefixime group, and in 25%, 44%, and 31%, respectively, of the TMP-SMX-resistant group (p < 0.001). Bacteriologic cure (day 3) occurred in 78% and 23% of the cefixime and TMP-SMX-resistant groups, respectively (p < 0.001). Clinical or bacteriologic relapse (day 12) was infrequent in both groups. The response to treatment of the cefixime and the TMP-SMX-susceptible groups was similar. No significant side effects were noted. We conclude that cefixime is superior to TMP-SMX in the treatment of suspected shigellosis in areas with a high rate of resistance to TMP-SMX.


Subject(s)
Cefotaxime/analogs & derivatives , Dysentery, Bacillary/drug therapy , Shigella/drug effects , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Adolescent , Cefixime , Cefotaxime/therapeutic use , Child , Child, Preschool , Diarrhea, Infantile/drug therapy , Diarrhea, Infantile/microbiology , Double-Blind Method , Female , Humans , Infant , Male , Prospective Studies , Shigella boydii/drug effects , Shigella flexneri/drug effects , Shigella sonnei/drug effects , Trimethoprim Resistance
16.
Pediatr Emerg Care ; 9(4): 191-4, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8367353

ABSTRACT

Because nationally accepted guidelines for the management of children with epiglottitis during transport have not been published, we surveyed physicians attending the 1990 Pediatric Critical Care Transport Leadership Conference in order to delineate current practices and to test for correlations between complications and methods of management. A 22-item questionnaire was distributed, addressing demographics, availability and composition of a designated transport team, methods of airway management, use of medications for sedation or paralysis, monitoring techniques, and complications encountered during transport. Forty-three of the 49 attendees completed the questionnaire (87.8%). Almost all were attending physicians (60.9% pediatric intensivists, 29.3% pediatric emergency physicians) practicing in tertiary care facilities (58.5% in children's hospitals, 41.5% in general hospitals). Eighty-three percent of centers had designated transport teams. For transfer of a child with suspected epiglottitis from a physician's office, virtually all respondents recommended transport by ambulance, 64% to the nearest facility and 36% directly to a tertiary care center. Regarding interhospital transfers, 49% recommended intubation prior to transport in all cases, whereas 49% considered it on an individual basis. The majority of respondents preferred nasal intubation. To prevent dislocation of the endotracheal tube, 79.1% recommended taping it to the face only (as opposed to around the skull), 70.7% administered paralytic agents, but only 35.2% used additional mechanical restraints.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Critical Care/methods , Epiglottitis/therapy , Transportation of Patients/methods , Ambulances , Canada , Child , Humans , Intubation, Intratracheal/methods , Patient Transfer/methods , Transportation of Patients/standards , United States
17.
J Appl Physiol (1985) ; 74(4): 1885-92, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8099906

ABSTRACT

We investigated the effects of a murine monoclonal antibody directed against the canine leukocyte CD11/18 adhesion complex (MAb R15.7) in a canine model of septic shock. Awake 2-yr-old purpose-bred beagles were studied 7 days before and 1, 2, 4, and 10 days after intraperitoneal placement of an Escherichia coli-infected fibrin clot. Starting 12 h before clot placement, animals received 0.5-1 mg/kg iv every 12 h (4 doses total) of either MAb R15.7 (MAb group, n = 8) or, as controls, murine serum protein (n = 8). After infected clot placement, all animals received antibiotic (ceftriaxne, 100 mg.kg-1.day-1 for 4 days). Two of eight control animals and four of eight MAb animals died (P = 0.4). During the first 8 h after clot placement, MAb animals, compared with control animals, had greater (P < 0.06) increases in serum endotoxin levels and higher (P < 0.05) neutrophil counts. Day 1 after clot placement, MAb animals, compared with control animals, had decreased (P < 0.05) central venous pressure and arterial pH and increased (P < 0.05) arterial lactate. Day 2 after clot placement, MAb animals, compared with control animals, had decreased (P < 0.05) cardiac index and mean arterial pressure. In summary, MAb R15.7, although associated with increased neutrophil counts, worsened serum endotoxemia, acidosis, and cardiovascular function in this canine model of septic shock. These data suggest that in septic shock, antibody directed against this leukocyte membrane protein complex may be harmful, possibly via impairment of normal leukocyte function.


Subject(s)
Antigens, CD , Cardiovascular System/injuries , Shock, Septic/immunology , Toxemia/immunology , Acid-Base Equilibrium , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/blood , CD11 Antigens , CD18 Antigens , Cardiovascular System/immunology , Dogs , Endotoxins/toxicity , Leukocyte Count , Neutrophils , Receptors, Leukocyte-Adhesion/immunology , Shock, Septic/blood , Shock, Septic/complications , Toxemia/blood , Toxemia/complications
18.
J Appl Physiol (1985) ; 74(2): 510-9, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8458764

ABSTRACT

We examined the ability of commonly used clinical parameters to quantify acute hemorrhage in dogs. Eight animals were bled 40 ml/kg body wt over 100 min. Ten hemodynamic and 20 blood laboratory parameters were obtained every 10 min to construct, with use of linear regression analysis, models that quantify blood loss. During model construction, the best indicator of quantity of hemorrhage was arterial base deficit [ABD; coefficient of variation (CV) 35%]. This model was more accurate (P < 0.05) than 27 others (CV range 43 to 63%) and similar to systolic (CV 40%) and mean (CV 40%) arterial pressures. In validation studies in 10 additional animals, our best models based on ABD and systolic and mean arterial pressures each unexpectedly showed a significant (P < 0.05) decrease in accuracy (CV 86, 57, and 60%, respectively) attributable to large baseline (before hemorrhage) variability among animals. To eliminate this variability, models based on changes from baseline measurements were investigated. The best predictor of change in blood volume was change in ABD (CV 27%). This model was significantly (P < 0.05) more accurate than any of 27 others (CV range 36 to 65%) and similar to change in venous base deficit and venous pH (each CV 31%). When validated, acid-base models such as ABD, venous pH, and arterial bicarbonate were the best predictors of volume change (CV range 28 to 40%). With the use of multivariate analysis, pairwise combinations of single parameter models (n = 465) improved prediction errors only minimally. In summary, most commonly used hemodynamic and blood indexes could not be validated as accurate measurements in quantifying hemorrhage. In contrast, changes in acid-base parameters were validated as moderately accurate predictors of blood volume changes and therefore may have utility in the assessment of patients with ongoing hemorrhage.


Subject(s)
Blood Volume/physiology , Hemorrhage/physiopathology , Acid-Base Equilibrium , Analysis of Variance , Animals , Blood Pressure/physiology , Body Weight/physiology , Dogs , Hemodynamics/physiology , Hemorrhage/blood , Models, Biological , Oxygen/blood , Regional Blood Flow/physiology , Regression Analysis
19.
Pediatrics ; 89(2): 302-6, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1734400

ABSTRACT

Aerosolized racemic epinephrine, but not L-epinephrine, is commonly used in treating croup. The efficacy and adverse effects of nebulized racemic and L-epinephrine in the treatment of laryngotracheitis were compared. Children 6 months to 6 years of age with a croup score of 6 or above were assigned in a randomized double-blind fashion to receive either racemic (n = 16) or L-epinephrine (n = 15) aerosols. Croup score, heart rate, blood pressure, respiratory rate, fraction of inspired oxygen, and oxygen saturation were recorded before treatment and at 5, 15, 30, 60, 90, and 120 minutes after the aerosol. Patients in both groups showed significant transient reduction of the croup score and respiratory rate following the aerosol (P less than .001), but there were no differences between treatment groups when croup score, heart rate, blood pressure, and respiratory rate were assessed over time. It is concluded that L-epinephrine is at least as effective as racemic epinephrine in the treatment of laryngotracheitis and does not carry the risk of additional adverse effects. L-Epinephrine is also more readily available worldwide, is less expensive, and can be recommended for this purpose.


Subject(s)
Croup/drug therapy , Epinephrine/therapeutic use , Racepinephrine , Aerosols , Double-Blind Method , Epinephrine/administration & dosage , Epinephrine/adverse effects , Female , Humans , Infant , Male , Prospective Studies
20.
Pediatr Emerg Care ; 7(3): 157-9, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1876506

ABSTRACT

Esophageal variceal bleeding owing to portal hypertension is a potential threat in pediatric patients awaiting liver transplantation. We report a case of a three-year-old boy with severe congenital hepatic fibrosis, Caroli's disease, and portal hypertension who developed a life-threatening variceal hemorrhage for the first time in his life during commercial air transport to a liver transplantation center. Factors precipitating variceal bleeding are discussed, particularly those resulting from changes in altitude. It is recommended that prophylactic treatment for variceal bleeding be at least considered in children awaiting liver transplantation prior to prolonged air transportation. Because of differences in capabilities of treatment providers in various locales, and because there are as yet no conclusive data, the treatment of choice must be decided on an individual basis. Equipment for treating in-flight hemorrhage should be available.


Subject(s)
Aerospace Medicine , Esophageal and Gastric Varices/complications , Gastrointestinal Hemorrhage/etiology , Hypertension, Portal/complications , Liver Transplantation , Transportation of Patients/standards , Atmospheric Pressure , Child, Preschool , Gastrointestinal Hemorrhage/epidemiology , Gastrointestinal Hemorrhage/prevention & control , Humans , Male , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...